Company Long-Term Loans and Borrowings: Kyverna (KYTX)
The price trend shown below illustrates the dynamics of Kyverna Therapeutics (KYTX), whose market strength is based on inelastic demand and a unique immune reprogramming method for treating lupus. The current metric stands at 0.03, while the absence of ready-made products leaves the company dependent on external financing. Business prospects rely on the success of CAR-T therapy trials and expansion into the systemic immune pathology treatment segment.
Kyverna (KYTX) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Kyverna Therapeutics|KYTX - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Kyverna Therapeutics, Inc|KYTX - Company Debts|Debt to Book Value Kyverna Therapeutics|KYTX - Company Long-Term Debt|Company Current Liabilities Kyverna Therapeutics|Quick Ratio kyvernatx.com
- earnings and multiples data:
Analysis of all company metrics:KYTX - kyvernatx.com
Asset managers require an objective assessment of long-term credit load to determine an issuer's financial stability. This metric aggregates all obligations with maturities exceeding one year, allowing for the identification of borrowing trends and liquidity risks. By analyzing the time series of a firm's long-term borrowings, an investor evaluates the company's ability to service its debt. For Kyverna Therapeutics (KYTX), this is critical when financing the costly cryo-logistics of cell therapy.
Competitors of Kyverna Therapeutics (KYTX)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|ZBIO - Company Long-Term Debt|IMNM - Company Long-Term Debts|GOSS (Gossamer Bio, Inc.) - Company Long-Term Liabilities|Long-Term Debt kalvista.com (KALV)|Company Long-Term Liabilities SEPN|Company Long-Term Debt PVLA|Company Long-Term Debts SVRA|RIGL - Long-Term Debt|Company Long-Term Debt AnaptysBio, Inc. ANAB|Company Long-Term Loans and Borrowings ATXS|ENGN - Company Long-Term Debt|RAPT (rapt.com) - Company Long-Term Indebtedness|JBIO: Company Long-Term Debts|Aclaris Therapeutics, Inc (ACRS) - Company Long-Term Debts|Company Long-Term Liabilities TLSA|CABA: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities VTYX (Ventyx Biosciences, Inc.)|Amount of Long-Term Liabilities THTX|Company Long-Term Debts AVTX (Avalo Therapeutics Inc.)|Company Long-Term Loans and Borrowings ELDN|Agenus - Company Long-Term Debts|Long-Term Debt climbbio.com|Zura Bio Limited (ZURA) - Company Long-Term Debt|aTyr Pharma Inc - Company Long-Term Loans and Borrowings|ADAG (Adagene Inc) - Company Long-Term Debts|Company Long-Term Debts Ikena Oncology, Inc.|Company Long-Term Debt Shattuck Labs, Inc. (STTK)|EQ: Long-Term Liabilities|Company Long-Term Debts CNTB (Connect Biopharma Holdings Limited)|Immunic Therapeutics (IMUX) - Long-Term Debt|ATRA: Company Long-Term Liabilities|IFRX - Company Long-Term Debts|XFOR (X4 Pharmaceuticals) - Company Long-Term Liabilities|ACET: Amount of Long-Term Liabilities|CELU (Celularity Inc) - Company Long-Term Debts|INmune Bio Inc (INMB) - Long-Term Debt Volume|Company Long-Term Debts BRNS|Company Long-Term Liabilities Kezar Life Sciences Inc KZR|Company Long-Term Debt SAB Biotherapeutics SABS|Long-Term Debt Volume akaritx.com (AKTX)|ENLV - Company Long-Term Debt|QTTB - Company Long-Term Debts|GOVX (GeoVax Labs Inc) - Company Long-Term Liabilities|Long-Term Debt Edesa Biotech Corp (EDSA)|Company Long-Term Liabilities IBIO|CARM (Carisma Tx) - Amount of Long-Term Liabilities|Company Long-Term Liabilities XTLB (XTL Biopharmaceuticals Ltd.)|boltbio.com - Company Long-Term Indebtedness|Company Long-Term Debt HCW Biologics HCWB|APVO (Aptevo Therapeutics, Inc.) - Long-Term Liabilities|AIM ImmunoTech - Company Long-Term Debts|Company Long-Term Loans and Borrowings ADTX (Aditxt)|GRI: Company Long-Term Debts|XORTX Therapeutics Inc (XRTX) - Company Long-Term Debts|Company Long-Term Debt ReShape Lifesciences|REVB: Company Long-Term Loans and Borrowings|Company Long-Term Debt Indaptus Therapeutics (INDP)|Company Long-Term Liabilities scinai.com SCNI|Company Long-Term Debts CALI (CalciMedica)|Company Long-Term Debts Affimed NV AFMD|ALLK: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings HOOK (HOOKIPA Pharma Inc.)|IGMS: Company Long-Term Debts|ITOS - Long-Term Debt Volume|Company Long-Term Debt Ocean Biomedical|Company Long-Term Liabilities TC BioPharm (Holdings) Plc (TCBP)|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)